- Home
- QFIN vs CRNX Comparison
QFIN vs CRNX Comparison
Compare QFIN & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QFIN
- CRNX
- Stock Information
- Founded
- QFIN 2016
- CRNX 2008
- Country
- QFIN China
- CRNX United States
- Employees
- QFIN N/A
- CRNX N/A
- Industry
- QFIN Finance: Consumer Services
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- QFIN Finance
- CRNX Health Care
- Exchange
- QFIN Nasdaq
- CRNX Nasdaq
- Market Cap
- QFIN 5.6B
- CRNX 5.2B
- IPO Year
- QFIN 2018
- CRNX 2018
- Fundamental
- Price
- QFIN $38.37
- CRNX $37.35
- Analyst Decision
- QFIN Strong Buy
- CRNX Strong Buy
- Analyst Count
- QFIN 1
- CRNX 10
- Target Price
- QFIN $37.50
- CRNX $74.40
- AVG Volume (30 Days)
- QFIN 940.1K
- CRNX 1.0M
- Earning Date
- QFIN 03-11-2025
- CRNX 02-26-2025
- Dividend Yield
- QFIN 3.08%
- CRNX N/A
- EPS Growth
- QFIN 42.14
- CRNX N/A
- EPS
- QFIN 4.99
- CRNX N/A
- Revenue
- QFIN $2,449,056,522.00
- CRNX $1,038,999.00
- Revenue This Year
- QFIN $6.26
- CRNX N/A
- Revenue Next Year
- QFIN $3.96
- CRNX $195.21
- P/E Ratio
- QFIN $7.69
- CRNX N/A
- Revenue Growth
- QFIN 9.41
- CRNX N/A
- 52 Week Low
- QFIN $13.71
- CRNX $35.24
- 52 Week High
- QFIN $40.31
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- QFIN 57.14
- CRNX 24.86
- Support Level
- QFIN $35.34
- CRNX $35.51
- Resistance Level
- QFIN $37.38
- CRNX $53.55
- Average True Range (ATR)
- QFIN 1.16
- CRNX 2.36
- MACD
- QFIN -0.15
- CRNX -1.41
- Stochastic Oscillator
- QFIN 72.14
- CRNX 10.14
About QFIN Qifu Technology Inc.
Qifu Technology Inc is a Credit-Tech platform in China. It provides credit services more accessible and personalized to consumers and SMEs through Credit-Tech services to financial institutions, whereby it deploys its technology solutions to help financial institutions identify the diversified needs of consumers and SMEs, effectively access prospective borrowers that are creditworthy through multi-channels, enhance credit assessment on prospective borrowers, and manage credit risks and improve collection strategies and efficiency, among others.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.